Anti‐Müllerian Hormone and Metabolic–Hormonal Profiles in Women With and Without Polycystic Ovary Syndrome: A Population‐Based Study
Endocrinology, Diabetes & Metabolism · 2026-09 · 9 (5)
DOI: 10.1002/edm2.70287 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, Diabetes & Metabolism, online erschienen am 30.07.2026. Verfasst von Fahimeh Ramezani Tehrani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Endocrinology Research Center, Research Institute for Endocrine Molecular Biology, Research Institute for Endocrine Sciences, Shahid Beh…. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Anti-Mullerian Hormone. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Department of the School of Medicine, Shahid Beheshti University of Medical Sciences.
Abstract (Originalsprache)
Introduction
Evidence regarding age‐related variation in anti‐Müllerian hormone (AMH) and its associations with hormonal and metabolic parameters in women with polycystic ovary syndrome (PCOS), healthy women, and those with isolated PCOS features remains inconsistent. This study aimed to address these gaps using a cross‐sectional, population‐based approach.
Methods
A total of 883 women aged 18–45 years were categorized into three groups: PCOS ( n = 124; Rotterdam criteria), suspicious (one PCOS criterion, n = 274), and healthy controls ( n = 485). The coefficient of determination (R 2 ) assessed age‐related AMH variation. Linear regression evaluated associations between AMH and hormonal and metabolic profiles. Age‐stratified multivariable logistic regression, adjusted for BMI, parity, and physical activity, examined associations between AMH and type 2 diabetes (T2DM), hypertension, metabolic syndrome (MetS), and dyslipidemia.
Results
Age explained nearly 40% of AMH variation in healthy women, but only 20% in those with PCOS. AMH was inversely correlated with BMI in healthy and suspicious groups, but not in PCOS. Among healthy women aged ≥ 35 years, higher AMH was associated with a 37% reduced likelihood of T2DM (OR: 0.63, 95% CI: 0.41–0.97). In contrast, among women with PCOS aged < 35 years, elevated AMH was associated with 2.6‐fold higher odds of MetS (OR: 2.6, 95% CI: 1.20–6.20). In the suspicious group, AMH correlated positively with free androgen index and prolactin.
Conclusion
AMH declines less with age in women with PCOS than in healthy women. Higher AMH may be protective against T2DM in older healthy women but indicates elevated metabolic risk in younger women with PCOS, suggesting that AMH may serve as a life‐course biomarker for metabolic risk stratification and personalized preventive strategies in women's healthcare.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Reproductive Endocrinology Research Center, Research Institute for Endocrine Molecular Biology, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Foundation for Research & Education Excellence, Vestavia Hills, Alabama, USA.
- Department of Pharmacology, School of Medicine & Neurobiology Research Center, Institute of Neuroscience and Cognition, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Fahimeh Ramezani Tehrani, Maryam Mousavi, Marzieh Saei Ghare Naz, Maryam Farahmand, Masoumeh Jorjani, Fatemeh Mahboobifard
Förderung
- Research Department of the School of Medicine, Shahid Beheshti University of Medical Sciences
Zitieren
APA
Ramezani Tehrani, F., Mousavi, M., Saei Ghare Naz, M., Farahmand, M., Jorjani, M., & Mahboobifard, F. (2026). Anti‐Müllerian Hormone and Metabolic–Hormonal Profiles in Women With and Without Polycystic Ovary Syndrome: A Population‐Based Study. Endocrinology, Diabetes & Metabolism, 9(5). https://doi.org/10.1002/edm2.70287
Vancouver
Ramezani Tehrani F, Mousavi M, Saei Ghare Naz M, Farahmand M, Jorjani M, Mahboobifard F. Anti‐Müllerian Hormone and Metabolic–Hormonal Profiles in Women With and Without Polycystic Ovary Syndrome: A Population‐Based Study. Endocrinology, Diabetes & Metabolism. 2026;9(5). doi:10.1002/edm2.70287
BibTeX
@article{RamezaniTehrani2026,
author = {Ramezani Tehrani, Fahimeh and Mousavi, Maryam and Saei Ghare Naz, Marzieh and Farahmand, Maryam and Jorjani, Masoumeh and Mahboobifard, Fatemeh},
title = {Anti‐Müllerian Hormone and Metabolic–Hormonal Profiles in Women With and Without Polycystic Ovary Syndrome: A Population‐Based Study},
journal = {Endocrinology, Diabetes & Metabolism},
year = {2026},
volume = {9},
number = {5},
doi = {10.1002/edm2.70287}
}
EUVIMED